News and Announcements
Arthritis Relief Plus Annual Update 2016; US FDA Compliance Completed, Australian Government Support & First Commercial Batch in US
- Published January 17, 2017 5:08PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Arthritis Relief Plus Ltd (ARP) attained countless achievements during 2016.
- The company managed to complete US FDA compliance, securing an OTC topical drug status/ classification for 4Jointz.
- With also securing Australian Government support in the first cohort at the Rocketspace LandingPad in San Francisco.
- ARP also were awarded the Queensland Government Ignite grant, with commencing production of the first commercial batch of 4 Jointz in the USA.
- ARP also received to its advantage, national and regional broadcasting news coverage of its product throughout Australia.
- Finally, ARP secured a new investment offer which opened to fund the USA market growth and prepare for the global market partnering/licensing activities.